• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氟喹在泰国急性恶性疟患者中的药代动力学和药效学

Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria.

作者信息

Karbwang J, Bangchang K N, Bunnag D, Harinasuta T

机构信息

Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

Bull World Health Organ. 1991;69(2):207-12.

PMID:1860148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2393087/
Abstract

A double-blind randomized comparative study of the pharmacokinetics and pharmacodynamics of a single oral dose of 750 mg or 1250 mg of mefloquine was carried out on 20 Thai male patients with acute uncomplicated falciparum malaria. In the 750-mg group, one patient exhibited an RII response, while the others responded to the treatment with a mean fever clearance time of 50.2 +/- 28.2 hours and a mean parasite clearance time of 70.2 +/- 17.3 hours. The main adverse effects were dizziness, nausea, vomiting, abdominal pain, and diarrhoea. Electrocardiogram monitoring detected sinus bradycardia in three patients and sinus arrhythmia in three others. In the 1250-mg group, one patient exhibited an RII response, while the others responded to the treatment with a mean fever clearance time of 43.4 +/- 36.6 hours and a mean parasite clearance time of 73.4 +/- 25.2 hours. However, during the follow-up period, two patients recrudesced on day 23 and on day 31 (RI response). Dizziness, nausea, vomiting, abdominal pain, and diarrhoea were the major adverse effects, with dizziness being more frequent compared with the 750-mg group. Sinus bradycardia occurred in four patients and sinus arrhythmia in four others. The pharmacokinetics of the two regimens were similar, with the absorption of mefloquine increasing linearly with the dose; however, vomiting within an hour of taking the drug reduced the whole blood mefloquine concentrations. The results do not indicate that there is any advantage in using a single dose of 1250 mg of mefloquine rather than 750 mg.

摘要

对20名患有急性非复杂性恶性疟的泰国男性患者进行了一项双盲随机对照研究,比较单次口服750毫克或1250毫克甲氟喹的药代动力学和药效学。在750毫克组中,1名患者出现RII反应,其他患者对治疗有反应,平均退热时间为50.2±28.2小时,平均寄生虫清除时间为70.2±17.3小时。主要不良反应为头晕、恶心、呕吐、腹痛和腹泻。心电图监测发现3例患者出现窦性心动过缓,另外3例出现窦性心律失常。在1250毫克组中,1名患者出现RII反应,其他患者对治疗有反应,平均退热时间为43.4±36.6小时,平均寄生虫清除时间为73.4±25.2小时。然而,在随访期间,2例患者分别在第23天和第31天复发(RI反应)。头晕、恶心、呕吐、腹痛和腹泻是主要不良反应,与750毫克组相比,头晕更为常见。4例患者出现窦性心动过缓,另外4例出现窦性心律失常。两种治疗方案的药代动力学相似,甲氟喹的吸收随剂量呈线性增加;然而,服药后1小时内呕吐会降低甲氟喹全血浓度。结果并未表明使用1250毫克单剂量甲氟喹比750毫克有任何优势。

相似文献

1
Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria.甲氟喹在泰国急性恶性疟患者中的药代动力学和药效学
Bull World Health Organ. 1991;69(2):207-12.
2
Pharmacokinetics of mefloquine alone or in combination with artesunate.单独使用或与青蒿琥酯联合使用时甲氟喹的药代动力学。
Bull World Health Organ. 1994;72(1):83-7.
3
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.一项开放、随机试验,比较青蒿琥酯联合标准剂量甲氟喹分两天或三天给药,进行为期三天的治疗,用于治疗急性非复杂性恶性疟。
Southeast Asian J Trop Med Public Health. 2005 May;36(3):591-6.
4
Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine.泰国东部的恶性疟:单剂量甲氟喹疗效的随机试验
Bull World Health Organ. 1994;72(1):73-8.
5
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.青蒿琥酯口服制剂与奎宁加四环素治疗急性非复杂性恶性疟的比较。
Bull World Health Organ. 1994;72(2):233-8.
6
Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.甲氟喹、周效磺胺和乙胺嘧啶治疗有症状恶性疟:一项确定最有效剂量的双盲试验
Bull World Health Organ. 1987;65(3):363-7.
7
Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand.在泰国进行的卤泛群治疗急性非复杂性恶性疟的临床试验。
Southeast Asian J Trop Med Public Health. 1993 Mar;24(1):43-8.
8
Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand.疟疾:卤泛群(WR 171,669)在泰国初期现场试验中的治疗效果。
Bull World Health Organ. 1988;66(2):227-35.
9
A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand.甲氟喹在泰国耐氯喹恶性疟患者中的II期临床试验。
Bull World Health Organ. 1983;61(2):299-305.
10
Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.青蒿琥酯与甲氟喹在不同间隔时间用于治疗非重症恶性疟。
Am J Trop Med Hyg. 2004 Aug;71(2):160-6.

引用本文的文献

1
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review.奎宁和结构相关抗疟药物的致心律失常性心脏毒性:系统评价。
BMC Med. 2018 Nov 7;16(1):200. doi: 10.1186/s12916-018-1188-2.
2
Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients.甲氟喹治疗急性恶性疟:3673例患者非严重不良反应的前瞻性研究。
Bull World Health Organ. 1995;73(5):631-42.
3
Pharmacokinetics of mefloquine alone or in combination with artesunate.单独使用或与青蒿琥酯联合使用时甲氟喹的药代动力学。
Bull World Health Organ. 1994;72(1):83-7.
4
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.甲氟喹:其抗疟活性、药代动力学特性及治疗效果综述
Drugs. 1993 Mar;45(3):430-75. doi: 10.2165/00003495-199345030-00009.

本文引用的文献

1
A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand.甲氟喹在泰国耐氯喹恶性疟患者中的II期临床试验。
Bull World Health Organ. 1983;61(2):299-305.
2
Single-dose kinetics of mefloquine in Brazilian male subjects.甲氟喹在巴西男性受试者中的单剂量动力学
Bull World Health Organ. 1987;65(3):353-6.
3
Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.甲氟喹、周效磺胺和乙胺嘧啶治疗有症状恶性疟:一项确定最有效剂量的双盲试验
Bull World Health Organ. 1987;65(3):363-7.
4
Determination of mefloquine in biological fluids using high performance liquid chromatography.使用高效液相色谱法测定生物体液中的甲氟喹。
Southeast Asian J Trop Med Public Health. 1989 Mar;20(1):55-60.
5
Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.
Eur J Drug Metab Pharmacokinet. 1989 Jan-Mar;14(1):15-7. doi: 10.1007/BF03190836.
6
Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.用甲氟喹或乙胺嘧啶-磺胺多辛单剂量治疗恶性疟。
Bull World Health Organ. 1979;57(2):275-9.
7
Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090.盐酸甲氟喹(WR 142,490,一种喹啉甲醇类抗疟药)在大鼠体内的处置和代谢研究。对类似物WR 30,090的有限研究。
Drug Metab Dispos. 1975 May-Jun;3(3):198-210.